Acro Biomedical (ACBM) Net Cash Flow Growth (3y) (2018 - 2025)
Powered by 
Analysis
Acro Biomedical (ACBM) Net Cash Flow Growth (3y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 39.03% |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 26.05% |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 123.42% |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | - |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 656.54% |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | -41.14% |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 23.62% |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 72.08% |
| Sep 30, 2025 | 1.73% |
| Jun 30, 2025 | 91.33% |
| Mar 31, 2025 | -26.01% |
| Dec 31, 2024 | 84.41% |
| Sep 30, 2024 | 84.53% |
| Jun 30, 2024 | -84.05% |
| Mar 31, 2024 | -26.75% |
| Sep 30, 2023 | 66.63% |
| Jun 30, 2023 | 30.65% |
| Mar 31, 2023 | -36.95% |
| Dec 31, 2022 | -164.12% |
| Sep 30, 2022 | 28.32% |
| Jun 30, 2022 | -109.88% |
| Mar 31, 2022 | 108.43% |
| Dec 31, 2021 | -53.68% |
| Sep 30, 2021 | -159.85% |
| Jun 30, 2021 | 34.06% |
| Mar 31, 2021 | -76.21% |
| Sep 30, 2020 | -26.12% |